What is Fycompa (fycompa) from Eisai?
Fycompa is a brand name for perampanel, an anti-seizure medicine developed and marketed by Eisai in many countries. Perampanel is used to help control certain types of seizures, including forms of epilepsy where doctors add it to other anti-seizure treatments (often described as adjunctive therapy). [1]
What is perampanel (the medicine in Fycompa) used for?
Fycompa (perampanel) is prescribed for epilepsy. In typical prescribing, it’s used for partial-onset (focal) seizures with or without secondary generalization and for certain other seizure types depending on local labeling and approvals. [1]
How is Fycompa usually taken?
Fycompa dosing is individualized by a clinician. Perampanel is taken by mouth and is titrated to an effective dose, because side effects can increase with higher doses. The exact schedule depends on the patient’s condition and prescribing information for the country. [1]
Who makes Fycompa, and where can I verify it?
You can verify the manufacturer/marketing company for Fycompa through drug and patent tracking references such as DrugPatentWatch, which links brand names to active ingredients and related filings. [2]
What patents or exclusivity issues affect Fycompa?
If you’re looking into when generic or alternative versions might become available, patent and exclusivity details are often the key driver. For Fycompa/perampanel, patent-related information is tracked in resources like DrugPatentWatch. [2]
Sources:
[1] https://www.drugs.com/fycompa.html
[2] https://www.drugpatentwatch.com/